Search research articles
Contact Us
Filters
Showing results (101-110 of 204) with videos related to
Page
of 21
Sort By:
Antimicrobial Agents and Chemotherapy
|
December 18, 2019
The Novel Arylamidine T-2307 Demonstrates <i>In Vitro</i> and <i>In Vivo</i> Activity against Candida auris
Nathan P Wiederhold, Laura K Najvar, Rosie Jaramillo, et al.
The Journal of Antimicrobial Chemotherapy
|
December 2, 2015
The novel arylamidine T-2307 demonstrates in vitro and in vivo activity against echinocandin-resistant Candida glabrata
Nathan P Wiederhold, Laura K Najvar, Annette W Fothergill, et al.
Antimicrobial Agents and Chemotherapy
|
November 6, 2013
A reference laboratory experience of clinically achievable voriconazole, posaconazole, and itraconazole concentrations within the bloodstream and cerebral spinal fluid
Nathan P Wiederhold, Gennethel J Pennick, Sheryl A Dorsey, et al.
Journal of Clinical Microbiology
|
May 1, 2002
Candida glabrata oropharyngeal candidiasis in patients receiving radiation treatment for head and neck cancer
Spencer W Redding, William R Kirkpatrick, Brent J Coco, et al.
Antimicrobial Agents and Chemotherapy
|
March 11, 2015
Efficacy of the investigational echinocandin ASP9726 in a guinea pig model of invasive pulmonary aspergillosis
Nathan P Wiederhold, Laura K Najvar, Satoru Matsumoto, et al.
Medical Mycology
|
March 17, 2007
Candida krusei sepsis secondary to oral colonization in a hemopoietic stem cell transplant recipient
Steven D Westbrook, William R Kirkpatrick, Cesar O Freytes, et al.
Journal of Clinical Pathology
|
November 4, 2011
Antifungal treatment affects the laboratory diagnosis of invasive aspergillosis
Elaine McCulloch, Gordon Ramage, Ranjith Rajendran, et al.
Experimental Parasitology
|
February 23, 2011
Human p38 mitogen-activated protein kinase inhibitor drugs inhibit Plasmodium falciparum replication
Michael J Brumlik, Standwell Nkhoma, Mark J Kious, et al.
Open Forum Infectious Diseases
|
August 6, 2020
Invasive Aspergillosis as an Under-recognized Superinfection in COVID-19
George R Thompson Iii, Oliver A Cornely, Peter G Pappas, et al.
Virulence
|
June 9, 2016
Repurposing auranofin as an antifungal: In vitro activity against a variety of medically important fungi
Nathan P Wiederhold, Thomas F Patterson, Anand Srinivasan, et al.
Page
of 21
Search research articles
Search
Showing results (101-110 of 204) with videos related to
Sort By:
Page
of 21
Antimicrobial Agents and Chemotherapy
|
December 18, 2019
The Novel Arylamidine T-2307 Demonstrates <i>In Vitro</i> and <i>In Vivo</i> Activity against Candida auris
Nathan P Wiederhold, Laura K Najvar, Rosie Jaramillo, et al.
The Journal of Antimicrobial Chemotherapy
|
December 2, 2015
The novel arylamidine T-2307 demonstrates in vitro and in vivo activity against echinocandin-resistant Candida glabrata
Nathan P Wiederhold, Laura K Najvar, Annette W Fothergill, et al.
Antimicrobial Agents and Chemotherapy
|
November 6, 2013
A reference laboratory experience of clinically achievable voriconazole, posaconazole, and itraconazole concentrations within the bloodstream and cerebral spinal fluid
Nathan P Wiederhold, Gennethel J Pennick, Sheryl A Dorsey, et al.
Journal of Clinical Microbiology
|
May 1, 2002
Candida glabrata oropharyngeal candidiasis in patients receiving radiation treatment for head and neck cancer
Spencer W Redding, William R Kirkpatrick, Brent J Coco, et al.
Antimicrobial Agents and Chemotherapy
|
March 11, 2015
Efficacy of the investigational echinocandin ASP9726 in a guinea pig model of invasive pulmonary aspergillosis
Nathan P Wiederhold, Laura K Najvar, Satoru Matsumoto, et al.
Medical Mycology
|
March 17, 2007
Candida krusei sepsis secondary to oral colonization in a hemopoietic stem cell transplant recipient
Steven D Westbrook, William R Kirkpatrick, Cesar O Freytes, et al.
Journal of Clinical Pathology
|
November 4, 2011
Antifungal treatment affects the laboratory diagnosis of invasive aspergillosis
Elaine McCulloch, Gordon Ramage, Ranjith Rajendran, et al.
Experimental Parasitology
|
February 23, 2011
Human p38 mitogen-activated protein kinase inhibitor drugs inhibit Plasmodium falciparum replication
Michael J Brumlik, Standwell Nkhoma, Mark J Kious, et al.
Open Forum Infectious Diseases
|
August 6, 2020
Invasive Aspergillosis as an Under-recognized Superinfection in COVID-19
George R Thompson Iii, Oliver A Cornely, Peter G Pappas, et al.
Virulence
|
June 9, 2016
Repurposing auranofin as an antifungal: In vitro activity against a variety of medically important fungi
Nathan P Wiederhold, Thomas F Patterson, Anand Srinivasan, et al.
Page
of 21